English Korean Chinese
ホーム > 市場調査レポート > バイオテクノロジー > 遺伝子療法/RNAi > シンガポールにおける核酸試験市場動向
カテゴリ
バイオテクノロジー (1630)
オーダーメイド医療 (51)
ゲノム創薬 (203)
バイオマーカー (158)
バイオマテリアル (54)
バイオ機器 (385)
遺伝子療法/RNAi (103)
抗体/免疫 (194)
再生医療 (122)
分子標的療法 (132)
市場調査レポート

シンガポールにおける核酸試験市場動向

Nucleic Acid Testing Markets in Singapore

発行 Frost & Sullivan
出版日 2006年05月 商品コード 42339
ページ情報 英文 58 pages
価格
詳細については [お問い合わせ] ボタンよりお問い合わせ下さい。

原文目次

Abstract

This Frost & Sullivan research service entitled Nucleic Acid Testing Markets in Singapore gives an overview of the current status of the nucleic acid testing market in Singapore and discusses present and potential revenues. The study also discusses the prevailing industry challenges and gives an overview of the reimbursement system and regulatory environment for NAT in Singapore

Table of Contents

1 MARKET OVERVIEW

  • Overview
    • Singaporean Nucleic Acid Testing Markets Overview

2 RESEARCH OVERVIEW

  • Research Scope and Methodology
    • Research Scope
    • Research Methodology
    • Glossary of Terms
  • Research Process
    • Primary Interviews
    • Secondary Research
    • Questionnaire Development
    • Analysis

3 MARKET DYNAMICS

  • Market Drivers and Restraints
    • Market Drivers
    • Market Restraints

4 MARKET ANALYSIS

  • Market Engineering Measurements
    • Singaporean Market Engineering Measurements

5 DISEASE PROFILE

  • About Disease Profile
    • Disease Profile in Singapore

6 DISTRIBUTION CHANNEL ANALYSIS

  • About Distribution Channel Analysis
    • Distribution Channel Analysis in Singapore

7 COMPETITIVE ANALYSIS

  • About Competitive Analysis
    • Competitors' Profiles in Singapore

8 RESEARCH IN ACADEMIC INSTITUTIONS

  • About NAT Research in Academic Institutions
    • Research in Academic Institutions in Singapore

9 REIMBURSEMENT ISSUES AND STATUS

  • Reimbursement Issues and Status
    • Reimbursement Issues and Status

10 CONCLUSION

  • Strategic Recommendations
    • Overview
    • Flexible Pricing Package to Cater for Different End-user Groups
    • Automation and Integration and Future Add-On Possibilities
    • Open Platform System to Avoid Incompatibilities
    • Organize Educational Programs Regularly to Promote The Benefits of NAT
    • Collaborate With Healthcare/Academic Institutes to Conduct Validation Studies
    • Obtain Accreditation to Increase the Confidence in the Quality of Products and Services
    • Provide Customized Total Solution Services to End Users

11 FROST & SULLIVAN AWARDS

  • Frost & Sullivan Awards - Asia Pacific
    • Customer Service Leadership Award
    • Technology Innovation Award
    • Vertical Market Penetration Leadership Award
    • Competitive Strategy Leadership Award

12 APPENDIX

  • Appendix
    • Appendix 1: Government Healthcare Expenditure in Singapore From FY2002 to FY2004.
    • Appendix 2: R&D Expenditure by Type of R&D and Field of Science and Technology in Singapore for 2002.
    • Appendix 3: R&D Expenditure by Type of R&D and Field of Science and Technology in Singapore for 2003.
    • Appendix 4: R&D Expenditure by Type of R&D and Field of Science and Technology in Singapore for 2004.
    • Appendix 5: Pricing Information for NAT related Instruments and Kits in Singapore for 2006.
Back to Top